20報の論文が2020年第2四半期に発表されました

20報のQPatchやQubeを使用した査読付き論文が2020年第2四半期に出版されました.TMEM16 Aと嚢胞性線維症,薬剤誘発性QT延長,てんかん治療のためのNav1.1活性化剤,抗菌ペプチド,などの報告が世界中の様々なSophion製品ユーザー様(Amgen, AbbVie, Acesion Pharma, アステラス製薬, Evotec, 南洋理工大学)より発表されました.クイーンズランド大学からは5報,Sophion からは2報発表されています.

Al-Sabi et Al. 2020. “Development of a Selective Inhibitor for Kv1.1 Channels Prevalent in Demyelinated Nerves.” Bioorganic Chemistry 100(July 2019): 103918.

Chow et Al. 2020. “A Selective NaV1.1 Activator with Potential for Treatment of Dravet Syndrome Epilepsy.” Biochemical Pharmacology (February): 113991.

Diness et Al. 2020. “Inhibition of KCa2 Channels Decreased the Risk of Ventricular Arrhythmia in the Guinea Pig Heart During Induced Hypokalemia.” Frontiers in Pharmacology 11(May): 1–10.

Gonzales et Al. 2020. “Fluorescence Labeling of a NaV1.7-Targeted Peptide for near-Infrared Nerve Visualization.” EJNMMI Research 10(1): 49.

Henckels et Al. 2020. “Development of a QPatch-Automated Electrophysiology Assay for Identifying TMEM16A Small-Molecule Inhibitors.” ASSAY and Drug Development Technologies 18(3): 134–47.

Hirsch et Al. 2020. “Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis Tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria.” Microorganisms 8(5): 626.

Israel et Al. 2020. “Characterization of Synthetic Tf2 as a NaV1.3 Selective Pharmacological Probe.” Biomedicines 8(6 Special Issue “Animal Venoms–Curse or Cure?”).

Koshman et Al. 2020. “Drug-Induced QT Prolongation: Concordance of Preclinical Anesthetized Canine Model in Relation to Published Clinical Observations for Ten CiPA Drugs.” Journal of Pharmacological and Toxicological Methods 103(February): 106871.

Kuramoto et Al. 2020. “Novel Indirect AMP-Activated Protein Kinase Activators: Identification of a Second-Generation Clinical Candidate with Improved Physicochemical Properties and Reduced HERG Inhibitory Activity.” Chemical and Pharmaceutical Bulletin 68(5): 452–65.

Lacivita et Al. 2020. “Privileged Scaffold-Based Design to Identify a Novel Drug-like 5-HT7 Receptor-Preferring Agonist to Target Fragile X Syndrome.” European Journal of Medicinal Chemistry 199: 112395.

Liao et Al. 2020. “Design, Synthesis and Biological Activity of Novel 2,3,4,5-Tetra-Substituted Thiophene Derivatives as PI3Kα Inhibitors with Potent Antitumor Activity.” European Journal of Medicinal Chemistry 197: 112309.

McGivern et Al. 2020. “Ion Channels and Relevant Drug Screening Approaches.” SLAS DISCOVERY: Advancing the Science of Drug Discovery 25(5): 413–19.

McMahon et Al. 2020. “Pharmacological Activity and NMR Solution Structure of the Leech Peptide HSTX-I.” Biochemical Pharmacology: 114082.

Okumu et Al. 2020. “Novel Bacterial Topoisomerase Inhibitors Derived from Isomannide.” European Journal of Medicinal Chemistry 199: 112324.

Ong et Al. 2020. “Modulation of Lymphocyte Potassium Channel Kv1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin.” ACS Pharmacology & Translational Science: acsptsci.0c00035.

Qian et Al. 2020. “Screening Assay Protocols Targeting the Nav1.7 Channel Using Qube High-Throughput Automated Patch-Clamp System.” Current Protocols in Pharmacology 89(1): e74.

Rozenfeld et Al. 2020. “A Big Molecule Induces Schwann Cells in the Peripheral Nervous System Leading to Myelin Sheath Repair.” International journal of Diabetes & Endocrinology Research: 1–13.

Schupp et Al. 2020. “Electrophysiological Studies of GABAA Receptors Using QPatch II, the Next Generation of Automated Patch-Clamp Instruments.” Current Protocols in Pharmacology 89(1): e75.

Walsh 2020. “Screening Technologies for Inward Rectifier Potassium Channels: Discovery of New Blockers and Activators.” SLAS DISCOVERY: Advancing the Science of Drug Discovery 25(5): 420–33.

Zhu et Al. 2020. “Structural Optimization of Aminopyrimidine-Based CXCR4 Antagonists.” European Journal of Medicinal Chemistry 187: 111914.